Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of July 13th – 19th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
10. Jumping Ship From Cannabis to Psychedelics: Lessons Learned
Bruce Linton is One of the Classic Movers and Shakers in the Cannabis Industry—and Now in the Psychedelics Industry
Bruce Linton‘s former company, Canopy Growth (TSX: WEED) (NYSE: CGC) (FRA: 11L1), was one of the early leaders in the large and far-reaching cannabis industry. That business, like every other cannabis business, has had to manage some of the same sort of uncertainty that the Psychedelics industry is experiencing today.
READ FULL CANNABIS TO PSYCHEDELICS ARTICLE
9. A Mystical Journey: The Therapeutic Value of Sights and Sounds in Psychedelic Therapy
The More Enduring and Effective Transformative Effects of Using Psychedelics Are the Mystical Experiences Users Talk About that Totally Change How They Live Their Life
Many say these mystical experiences from Psychedelics became one of the most important events in their lives, as reported in a survey of 1,993 Psilocybin users by Johns Hopkins researchers. Approximately 60% of respondents considered their experience to be among the top 10 most psychologically and personally meaningful experiences of their lives.
READ FULL PSYCHEDELIC THERAPY ARTICLE
8. Red White & Bloom Appoints Renowned CNBC Financial Analyst Steve Grasso as Business Advisor
Grasso Regularly Speaks at a Multitude of Investment Conferences Across the U.S. and Also Takes Part in Business Round Tables with Many Influential Investors and Business Leaders
Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) announced hat the company has appointed Steve Grasso as its new business advisor. Grasso is well known throughout the financial community for his role at CNBC as a market analyst and is a regular on the top-rated CNBC show Fast Money, which airs daily Monday to Friday and boasts an average daily viewership that currently exceeds 250,000.
7. Canada Marijuana Dispensary Count Tops 1,000 For the First Time
The Province with the Highest Tally Probably Isn’t the One You’d Expect
In less than two years after the country legalized recreational cannabis, Canada has reached an important milestone. According to a report in BNN Bloomberg, the country’s dispensary count crossed the 1,000 mark as of July 17, landing at 1,010.
READ FULL CANADA CANNABIS ARTICLE
6. The Uptight Girl’s Guide to Psychedelics
Raves Have Been Postponed Indefinitely, the Tie-Dye Trend Has Crested, and Jam Bands Are… Divisive as Ever
But Psychedelic substances consistently make headlines: decriminalized in Oakland and Denver; shown to have promise treating PTSD, depression, and anxiety; inspiring a venture capitalist gold rush.
READ FULL PSYCHEDELICS ARTICLE
5. This Cannabis Catalyst is Particularly Powerful Now
For the Past Several Years, Specific Events Have Driven Cannabis Stock Prices Most of the Time
Some, like Constellation Brands (NYSE: STZ) (FRA: CB1A) investing in Canopy Growth (TSX: WEED) (NYSE: CGC) (FRA: 11L1), have been surprises, while many have been scheduled. Some of those that stand out include Colorado legalizing at the beginning of 2014, the 2016 elections, California legalizing at the beginning of 2018 and Canada legalizing in October 2018. In all cases, these events proved to be buy-the-rumour and sell-the-news items.
READ FULL CANNABIS CATALYST ARTICLE
4. GOP Congressman Withdraws Amendment to Block D.C. Psychedelics Decriminalization
Rep. Andy Harris (R-MD) Made the Case That HIs Proposed Measure Represented a Reasonable Compromise
A GOP congressman filed an amendment to a spending bill on Wednesday, seeking to undermine a local Washington, D.C. ballot initiative to deprioritize enforcement of laws against a broad class of Psychedelics.
READ FULL DC PSYCHEDELICS ARTICLE
3. Cannabis is a World of Mystery, Says a Nobel Prize Winner Working in Weed
Earlier This Year, Israel-Based Cannabis Pharma Firm Panaxia Pharmaceutical Appointed Nobel Prize Winner in Chemistry, Prof. Aaron Ciechanover to its Advisory Committee
Prof. Ciechanover, an Israeli biologist, got the highest honour from the Nobel Foundation for discovering ubiquitin‐mediated protein degradation. He is now one of the very few Nobel Prize winners actually working in the cannabis space.
They Worked for My Depression – Could They Be the Future of Psychiatry?
Psychedelic drug therapy subverts the timeworn patriarchal hierarchy by creating an atmosphere of cooperation and trust rather than competition and domination.
READ FULL PSYCHEDELIC MEDICINE ARTICLE
1. Biden and Trump Must Back Marijuana Legalization Before Election, NORML Petition Demands
NORML Stressed That Most Americans, Including a Majority of Republicans and a Supermajority of Democrats, Are in Favor of Marijuana Legalization
A top marijuana advocacy group is circulating a petition urging President Trump and presumptive Democratic presidential nominee Joe Biden to back comprehensive cannabis reform ahead of the November election.
READ FULL CANNABIS LEGALIZATION ARTICLE
With U.S. Pot Stocks the Hot Theme of 2021, Here’s Why Red White & Bloom Could Be One of the Cannabis Sector’s Top Performers
Follow TCI on Social Media: Facebook | Instagram | Twitter | LinkedIn | Investor Group
Follow Psychedelic Profits on Social Media: Facebook | Twitter | LinkedIn | Investor Group
Did you enjoy this article? If so, sign up for our Email Newsletter below to start receiving our weekly recap of the week’s best articles.
The Most Anticipated U.S. Weed IPO of 2020 is Finally Here
Get Your Copy of The Ultimate Cannabis Investing Guide
Join the Discussion in the TCI Investor Group
Featured ArticlesCannabis Stock NewsCannabis Industry ArticlesTechnical Analysis ArticlesWatch Cannabis Stock Videos